Medicine moves
too slow

At Velsera, we're changing that.

Velsera in a nutshell

Velsera is a Health Tech company

providing advanced software enabled by expert services

that accelerates the discovery, development and delivery

of Precision Medicine globally.

We are on a mission to make breakthroughs happen faster,

so that lives are improved sooner.

Who we serve

Velsera accelerates clinical & discovery breakthroughs.

Clinical Diagnostic Labs

Accelerate the scale up of your genetic testing & unlock the value in your data.

NGS Assay & Equipment Manufacturers

Bring new tests to market and scale up testing fast.

Biotech &
Pharma

Accelerate your research breakgthroughs and novel drug launches.

Non-Profits and Government Agencies

Accelerate your research breakthroughs and unlock the value in your data.

Velsera is uniquely able to accelerate across the gap between Clinical & Discovery.

Velsera pushes medicine forward

As one of the largest omics analytics providers in the market

80+

Active clinical NGS lab customers

250,000+

NGS samples sequences

20+

Productized NGS assays available 'off the shelf'

+20% p.a.

Year over year sequencing volume

Advancing breakthrough discoveries to tackle the world's most pressing health challenges

7/10

Top pharmas supported by our technology-enabled products and services

1800+

Researchers using the Seven Bridges Platform

1.7 Million

Patients

48 PB

Of multi-omic molecular data

Trusted widely across the industry

A selection of our customers

Velsera solves problems by combining deep expertise with cutting edge tech

Powerful platforms

One singular vision

Technology designed to accelerate the momentum of medicine

 

Clinical Genomics Workspace

Our tertiary analytics & reporting tool for clinical NGS diagnostics.

Knowledgebase

Our best in class, IVD-grade variant interpretation knowledge base.

Seven Bridges

Our Trusted Research Environment (TRE) for bioinformatic analysis & pipeline development.

ARIA

Our data harmonization and secure sharing platform.

GRAF

Our award winning reference genome tool.

FastFinder

High throughput for PCR made simple.

Expert services

Unified for impact

Services crafted to drive transformative advancements in healthcare

 

Clinical

Supporting diagnostic labs to start and scale-up their NGS testing.

Regulatory

Supporting clinical diagnostic labs and diagnostic test developers to navigate the changing regulatory environment.

Data Harmonization

Supporting health & life science companies to combine and harmonize their data.

Bioinformatics

Supporting researchers and diagnostic developers to build better workflows

Scientific

Supporting researchers to run efficient and effective studies.

Our Integrated Solutions ‘menu’.

 

Clinical Interpretation & Reporting

Accelerate the scale up of your genetic testing & unlock the value in your data.

IVD Compliance Transition

Effectively navigate and grow in the changing regulatory environment.

NGS Assay Development & Expansion

Bring new tests to market and scale-up fast.

Companion Diagnostic Development & Scaling

Develop better diagnostics that scale faster, accelerating novel drug uptake.

Clinical & 'Omic Data Unlock

Harmonize and augment your data to unlock the value within.

Analysis & Bioinformatics

Use cutting edge technology to make new discoveries and breakthroughs faster.

Testimonials

Hear how leading life sciences companies and clinical diagnostic labs trust our technology to accelerate discovery and improve patient care.

Velsera has been a great partner enabling our NGS offering so we can improve the quality and speed of patient care. With Velsera's team and technology, we have been able to streamline our workflow and customize our clinical report. We can run various assays using the single Velsera platform. And our physicians are highly complementary of the report we created with Velsera given the content and aesthetic.

Jen Gass

Associate Director, Genetics Laboratory / Florida Cancer Specialists

The Clinical Genomics Workspace (CGW) by Velsera has provided our laboratory with a seamless, integrated software solution that allows us to spend more time analyzing the sequencing data and generating clinical reports and less time worrying about logistics.

James Patrick Solomon, M.D., Ph.D.

Medical Director, Clinical Genomics Laboratory / Weill Cornell Medicine

Using standard computational tools, we are already finding a large number of novel variants of African and Native American ancestries within the Brazilian genomes. We want to use the graph-based approach in order to capture the full value of our genomes.

Interpreting large-scale, complex transcriptomics data is critically important for understanding the molecular and cellular basis of disease. We are confident that by working with the unique multi-cloud technology developed by Velsera and by benefiting from the depth and breadth of their expertise in bioinformatics and cloud computing, these solutions will assist us in maximizing the value of the data we generate.

Pharma Leader

Vice President, Medicinal Sciences / Top 10 Global Biopharmaceutical Company

There's going to be a bottleneck in the professional component as well sometimes. Velsera allowed us to widen that bottleneck and to have more uniformity of reporting.

Eric Loo, MD

Asst. Professor, Pathology and Lab Medicine / Dartmouth-Hitchcock Health